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doi:10.1016/j.ejvs.2008.01.026Abstract Objectives: To assess health-related quality of life (HRQoL) up to 24 months after
successful infrageniculate bypass surgery for limb-threatening ischaemia.
Methods: 89 patients with infrageniculate bypass surgery for limb-salvage were studied. HRQoL
was assessed using the Short Form (SF)-36v1 questionnaire before, 6, 12, and 24 months after
revascularisation.
Results: 47 patients (53%) with intact limb and functioning graft were assessed after 24 months,
27 patients (30%) died, further 7 required secondary amputation, 3 suffered irremediable graft
occlusion, and4were lost to follow-up. The24-monthsHRQoL-valueswere significantly improved
in 4 domains: physical functioning (p< 0.01), bodily pain (p< 0.01), mental health (pZ 0.04),
and social functioning (pZ 0.01). Except for baseline-values, HRQoL remained inferior in dia-
betics compared to non-diabetics throughout follow-up. Maximum improvement of HRQoL was
delayed in diabetics (12months vs. 6months) and less pronounced. After 24months non-diabetic
patients maintained improvement in 5 domains and diabetic patients only in bodily pain.
Conclusions: Improvement in HRQoL is sustained for more than 12 months after successful
infrageniculate bypass surgery. Therefore, an aggressive approach towards revascularisation
seems to be justified from the patient’s perspective. However, this benefit in quality of life is less
in diabetic patients, despite similar limb-salvage rates.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.rdt, MD, Division of Vascular Surgery, Military Hospital Ulm, Oberer Eselsberg 40, D-89081 Ulm,
x: þ49 731 1710 1230.
b.de (M. Engelhardt).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
64 M. Engelhardt et al.Introduction follow-up periods of 6, 12, and 24 months, respectively. ATable 1 Patient demographics, risk factors, and co-
morbid diseases (nZ 89)
Demographics
Age 71 (IQR, 64e77.5) years
Male 64 (72%)
Risk factors
Diabetes 53 (60%)
Hypertension 80 (90%)
Hyperlipidaemia 48 (54%)
Smoking
Never 32 (36%)
Former 31 (35%)
Current 26 (29%)
Co-morbid diseases
CABG 11 (12%)
MI 18 (20%)
CHF 8 (9%)
TIA 2 (2%)
Stroke 16 (18%)
ESRD 1 (1%)
CABG, coronary artery bypass grafting; MI, myocardial infarc-
tion; CHF, congestive heart failure; TIA, transient ischaemic
attack; ESRD, end-stage renal disease.Infrainguinal bypass surgery is a well established treatment
for patients with critical limb ischaemia (CLI), and some
specialized centres attempt some type of revascularisation
in as many as 90% of patients with limb-threatening
ischaemia.1 On the other hand, frequent adverse effects
such as delayed wound healing, prolonged recovery from
surgery, readmissions, and the need for repeated endovas-
cular and surgical treatment for maintenance of graft
patency,2,3 raise question about the appropriateness of
femoro-distal bypass grafting in this problematic group of
patients with severe co-morbidities and limited life expec-
tancy. Therefore, it has repeatedly been pointed out that
traditional outcome measures, such as patency rates, alone
are not sufficient to judge the true value of infrainguinal
bypass surgery.4,5 Rather, more patient-based measures,
such as functional outcome and health-related quality of
life (HRQoL), should be taken into account as well.4,6,7
Meanwhile, there is a great body of evidence that
successful infrainguinal bypass surgery can be expected to
improve the severely impaired quality of life in patients
with CLI.8e18 While this improvement has well been docu-
mented for the first 6 to 12 months after revascularisation,
durability of this benefit beyond the first year still remains
unclear. The few long-term assessments of health status
and functional outcome after revascularisation for limb-
salvage indicate that the surviving patients are likely to
achieve limb salvage, but retain physical disabilities with
limited functional status and quality of life.19e23 To our
knowledge as yet there is no prospective, intermediate or
long-term assessment of HRQoL in patients with infrageni-
culate bypass surgery for limb-threatening ischaemia.
Previously we reported that early quality of life im-
provement after successful infrageniculate bypass surgery
is clearly less in patients with diabetes mellitus than in non-
diabetic patients.10 Delayed recovery from surgery and
problematic wound healing were suspected to be reasons
for this impaired benefit in the diabetic group. Unclear is
as yet, whether this adverse influence on HRQoL remains
throughout further follow-up.
Therefore, aim of this prospective study was to assess
the intermediate-term changes of HRQoL up to 24 months
after successful infrageniculate bypass surgery for limb-
threatening ischaemia, and to evaluate the influence of
diabetes on quality of life.
Materials and Methods
In part, the study methods have been reported previously.10
All patients with CLI scheduled for infrageniculate bypass
surgery at the Zentralklinikum Augsburg/Germany between
July 2002 and April 2004 were eligible for the study. The
patients were asked for their consent to be surveyed, and
to complete the Short Form (SF)-36 (Version 1) question-
naire for baseline assessment of their HRQoL before bypass
surgery. Patients unwilling to give consent or unable to
complete the Short Form (SF)-36 questionnaire were
excluded from the study.
Patients with successful revascularisation, defined as
functioning graft and intact limb, were reassessed afterlimb was considered intact, if major amputation could be
avoided and there was no foreseeable need for secondary
amputation in the near future. Standardized follow-up
included a physical examination and duplex scanning of
the infrageniculate bypass. Again, all patients were asked
to complete the SF-36 questionnaire. In addition, final
HRQoL-assessment after 2 years included patients with
failed arterial reconstruction, i.e. secondary amputation
or irremediable graft occlusion, as well. However, these
data were analyzed separately. In a subgroup-analysis,
HRQoL-scores of patients with diabetes (diabetic group)
and without diabetes (non-diabetic group) were compared.
The SF-36 questionnaire has been recommended as the
most appropriate generic quality of life assessment tool for
peripheral arterial disease.6,24,25 This instrument is a self-
assessment measure, containing 35 questions that cover
eight dimensions of health-related quality of life: physical
functioning, role-physical, bodily pain, social functioning,
mental health, role-emotional, vitality, and general health
perceptions.26 An additional item addresses the change in
general health status over time. A high score indicates
good health status from the patient’s perspective.
Data were collected and analysed using SPSS (Version
10.0) statistical software (SPSS, Munich, Germany). Non-
parametric Wilcoxon matched pairs test was used to
compare baseline and follow-up results, and the Mann-
Whitney U-test compared subgroups of the sample. Cumu-
lative patency rates, limb salvage rate, patient survival
rate, and amputation-free survival rate were calculated
by the Kaplan-Meier method using the log-rank test for
comparison. A p-value <0.05 was considered to be statisti-
cally significant.
Table 2 Outcomes 12 months and 24 months after infrageniculate bypass surgery for all patients and for the subgroups non-
diabetic and diabetic patients
Outcome rates Follow-up Follow-up 24 Months
12 Months 24 Months Non-Diabetes Diabetes p
Primary patency 85% 82% 81% 83% 0.94
Assisted primary patency 86% 86% 87% 84% 0.91
Secondary patency 90% 90% 88% 92% 0.59
Limb salvage 82% 81% 84% 78% 0.42
Patient survival 77% 65% 70% 61% 0.43
Amputation-free survival 69% 60% 65% 56% 0.30
Two-years Quality of Life after Bypass Surgery 65Results
Of 111 patients scheduled for infrageniculate bypass
surgery 22 refused to participate in the study, mainly due
to language barriers. These latter patients were revascu-
larised as planned, but were not considered for the study.
The baseline SF-36 questionnaire was completed by 89
patients (80%), who compromised our study group. Patient
demographics and co-morbid diseases are given in Table 1.
Indications for arterial reconstruction were presence of
rest pain in 16 patients (18%) (diabetic group, 11%), non-
healing ulceration in 32 (36%) (diabetic group, 36%), and
gangrene in 41 (46%) (diabetic group, 53%).Months
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Figure 1 HRQoL-values (physical functioning, role-physical, bod
and 24 months after successful infrageniculate bypass surgery (nZ
of SF-36 domains) (*p 0.01; **p 0.001; vs. baseline).Distal graft sites were the popliteal artery below knee in
46 (52%), tibial/peroneal vessels in 39 (44%), and pedal
arteries in 4 patients. The use of prosthetic grafts (ePTFE
18%, composite 9%) was limited to popliteal and proximal
tibial reconstructions. Outflow vessels were similarly
distributed in diabetic and non-diabetic patients with
infrapopliteal reconstructions in 55% and 52%, respectively.
During follow-up 27 patients (30%) died. Forty-seven
patients (53%) presented with patent grafts and intact
limbs at 24-months outcome assessment. Of these patients
12 (26%) underwent minor amputation (4 non-diabetic; 8
diabetic). By the time of final follow-up 29 patients (62%; 15
non-diabetic and 14 diabetic) had no PAD-specificMonths
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47; mean values with corresponding 95% confidence intervals
66 M. Engelhardt et al.complaints, 12 patients (26%) presented with claudication
(6 non-diabetic; 6 diabetic) and 6 patients with CLI: 2
patients with rest pain (all diabetic group) and 4 patients
with tissue loss (2 persistent lesions in diabetic patients,
and 2 new lesions in non-diabetic patients). Seven patients
(8%) required secondary amputation due to non-healing
wounds and persisting rest pain. Four (5%) patients suffered
irremediable graft occlusion, but were not amputated. One
patient with secondary amputation and one with untreated
graft occlusion refused to complete the SF-36 questionnaire
at final HRQoL-assessment. In total 4 (5%) patients were lost
to follow-up. The technical outcomes of bypass surgery are
presented in Table 2. In both, the diabetic and the non-di-
abetic group, similar outcome rates were obtained in terms
of clinical outcome (Table 2).
Twenty-four months after successful revascularisation
HRQoL was significantly improved in 4 domains of the SF-36
compared to baseline-values: physical functioning
(p< 0.01), pain (p< 0.01), mental health (pZ 0.04), and
social functioning (pZ 0.01) (Figs. 1 and 2). Likewise,
a trend toward improvement was observed in the domains
role-physical, role-emotional, and vitality (Figs. 1 and 2).
The time-course of postoperative HRQoL-values revealed
that the initial improvement after 6 months was most pro-
nounced, followed by a continuous decline during theMonths
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Figure 2 HRQoL-values (mental health, role-emotional, social fun
successful infrageniculate bypass surgery (nZ 47; mean values w
(*p< 0.05; **p 0.01; ***p 0.001; vs. baseline).following 18 months in all but one domain, physical func-
tioning (Figs. 1 and 2). However, only in general health per-
ceptions the poor baseline level was reached again by the
end of the follow-up period.
After 24 months, all patients with patent reconstruction
and intact limb judged their general health status as being
improved or at least similar compared to their situation
prior to surgery: ‘‘much better’’ 19 (40%), ‘‘better’’ 14
(30%), and unchanged 14 (30%).
Subgroup-analysis, comparing the diabetic and the non-
diabetic group, revealed that the over all benefit in HRQoL
can be attributed mainly to an improvement in the non-
diabetic group (Figs. 3 and 4). Prior to bypass surgery, both
groups did not differ significantly e except for the domain
role-emotional (pZ 0.04). During the complete follow-up
period, HRQoL-values in the non-diabetic group were supe-
rior to those of diabetic patients. While the non-diabetic
group reached a peak in HRQoL after 6 months, improve-
ment was delayed in the diabetic group with a maximum
after 12 months in most domains (Figs. 3 and 4). At final fol-
low-up examination, HRQoL-values of non-diabetic patients
were still significantly improved in all domains of physical
health (physical functioning, role-physical, and bodily
pain), as well as in mental health and social functioning
(Table 3). The diabetic subgroup sustained significantMonths
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Figure 3 Comparison of non-diabetic (nZ 21) (d) and diabetic (nZ 26) (- - -) patients (physical functioning, role-physical,
bodily pain, general health perceptions) before (baseline), 6, 12, and 24 months after successful infrageniculate bypass surgery
(mean values with corresponding 95% confidence intervals of SF-36 domains) (*p< 0.05; **p 0.01; ***p 0.001).
Two-years Quality of Life after Bypass Surgery 67improvement only in the domain bodily pain, whereas gen-
eral health perceptions were judged even worse than be-
fore surgery (Table 3).
The small group of patients with secondary amputation
self-assessed their HRQoL as being improved compared to
the preoperative situation, especially in the physical health
domains physical functioning and bodily pain (Table 3).
Asked whether they would give consent to bypass surgery
in the same preoperative situation once again, 4 patients
agreed and 1 patient denied (1 undecided). In patients
with non-treated graft occlusion (nZ 3) quality of life
was even further impaired compared to baseline-values,
except for the domains bodily pain and mental health which
remained nearly unchanged.Discussion
Chronic critical limb ischaemia has a progressively detri-
mental impact on quality of life.24,27,28 In recent years, it
has well been documented that successful infrainguinal
bypass surgery can improve this impaired HRQoL in patients
with limb-threatening ischaemia, at least for the first year
after revascularisation.8,9,11,12,14,15e17,29 Beyond that, the
present prospective study revealed that this benefit inHRQoL is sustained for a time period exceeding the first
12 months after surgery. An early significant improvement
of HRQoL 6 to 12 months after surgery, well in line with
previous reports,8,9,11e15,17 was followed by a slight decline
during the further observation period. Nevertheless, lasting
improvement could be sustained in 7 out of 8 domains of
HRQoL up to 24 months after successful revascularisation.
Likewise, the majority of patients felt general health status
being better than before surgery.
Previous reports on quality of life after bypass surgery
were in their majority limited to a 12 months follow-up
period, and only a few retrospective studies assessed
functional outcome or HRQoL with an observation period
exceeding the first year.19e23 The surviving patients were
likely to retain their limb after successful revascularisa-
tion,20,21 but their functional capabilities were impaired,
often necessitating significant care,21,23 and their overall
quality of life was poor compared to healthy controls.20e22
The only prospective long-term HRQoL-study by Wann-
Hansson et al. reported a decline of physical mobility
following an initial first year improvement of quality of
life.23 This development of quality of life values is analo-
gous to the results obtained in the present study, although
different tools for HRQoL-assessment were applied: the
Nottingham Health Profile (NHP) and the SF-36,
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Figure 4 Comparison of non-diabetic (nZ 21) (d) and diabetic (nZ 26) (- - -) patients (mental health, role-emotional, social
functioning, vitality) before (baseline), 6, 12, and 24 months after successful infrageniculate bypass surgery (mean values with cor-
responding 95% confidence intervals of SF-36 domains) (*p< 0.05; **p 0.01; ***p 0.001).
68 M. Engelhardt et al.respectively. However, in the Swedish study, the qualifying
procedures included endovascular reconstructions as well
as different types of open surgery, and only 36% patients
from the CLI-group could be included in the 4-year fol-
low-up assessment.23
In contrast to previous reports,8,11,12,14,17,20,23 this study
focuses on a homogenous group of patients with below-
knee bypasses for limb-threatening ischaemia. In these
patients, the benefit in quality of life seems particularly
questionable due to the high susceptibility of these recon-
structions to failure and the increased incidence of
ischaemic lesions and severe co-morbidities. Nevertheless,
even in this problematic group of patients, self-assessed
quality of life was substantially improved by successful
revascularisation.
In terms of graft patency and limb salvage, equally good
results can be achieved in diabetic and non-diabetic
patients after successful arterial reconstruction.30e32 On
the other hand, diabetes proved to be associated with pro-
longed wound healing,4 increased likelihood for loss of
ambulation,5,20 lower patient survival rates,31,33 and im-
paired quality of life at least within the first year after
revascularisation.11,15,20,34 In the present study, technical
outcome was similar in diabetic and non-diabetic patients
as well. However, in the diabetic group, postoperativeimprovement of quality of life was delayed, less pro-
nounced, and never reached the HRQoL-level observed in
the non-diabetic group. As the SF-36 is a generic health
status questionnaire, changes in general health status at-
tributable to numerous co-morbid diseases may adversely
affect responses despite functioning reconstruction and
intact limb.7 In diabetic patients, severe co-morbidities
and the progressive nature of these conditions continu-
ously reduce general health status. This may explain why
these patients encounter less improvement, and why their
limited benefit in quality of life is not sustained over a
longer period of time, despite functioning graft and limb
salvage.
As there is no control group without revascularisation,
no information is available on how untreated CLI-patients
would have done with respect to their quality of life during
the same follow-up period. Two years after infrageniculate
bypass surgery, HRQoL was superior or at least the same as
before surgery in all patients with successful revascularisa-
tion. With exception for the domain general health per-
ceptions, this observation was true even for the diabetic
group. There is every reason to believe that without
revascularisation HRQoL would continuously deteriorate in
patients with CLI.24 Therefore, maintenance of preopera-
tive baseline level alone might very well be regarded as
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Two-years Quality of Life after Bypass Surgery 69benefit, especially after a longer time-period such as 2
years.
Itwas not the primary aimof the present study to evaluate
HRQoL in patients with failed revascularisation. Surprisingly,
however, analysis of the small group of patients with
secondary amputation revealed there was no significant
difference in quality of life between patients with successful
revascularisation and those with secondary amputation e
the latter group even improved in the domains of physical
health compared to their baseline scores. Unexpectedly
good results in mobility and ‘‘activities of daily living’’
despite secondary amputation have been reported by John-
son and co-workers previously as well.12 However, as there
were few survivors with secondary amputation in our study,
and other working groups reported contrary observations
with negative impact of secondary amputation on quality
of life,22,35 these data do not justify the conclusion that qual-
ity of life of secondary amputees equates that of patients
with successful revascularisation two years after surgery.
A limitation of this study is the selection bias due to the
abbreviated survival of the study population. Furthermore,
especially patients with an unfavourable clinical outcome
may have refused to participate in the study any further.
This could result in an optimistic bias. While the limited
survival rate remains a general problem in longitudinal
studies on patients with CLI,36 including the present study,
the number of patients lost to follow up was, however,
rather small with only 4 patients after 24 months. There-
fore, the completed data sets can be expected to represent
the group of patients with functioning grafts and intact
limbs sufficiently.
In conclusion, infrageniculate bypass surgery has a last-
ing positive effect on self-assessed quality of life in patients
with CLI. Therefore, an aggressive approach towards bypass
surgery for limb-salvage seems to be justified from the
patient’s perspective. This seems especially true for pa-
tients without diabetes, who feel a gain in quality of life for
at least 2 years after successful revascularisation. Diabetic
patients tend to benefit as well, albeit to a lesser extent.
Considering the dismal prognosis CLI has for both life and
limb, this should not deter clinicians from attempting
revascularisation in the presence of diabetes, as quality
of life may at least be preserved for a limited period of
time. Hence, these findings may be of use when counselling
diabetic patients to provide them with a realistic picture of
what they may expect to encounter following infragenicu-
late bypass surgery.References
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